Amedeo Smart

Free Medical Literature Service



Alzheimer's Disease

  Free Subscription


1 Acta Neuropathol
2 Alzheimer Dis Assoc Disord
3 Alzheimers Dement
1 Brain
1 Brain Res
1 Curr Alzheimer Res
2 Exp Gerontol
1 Exp Neurol
1 Geriatrics (Basel)
4 J Alzheimers Dis
1 J Biol Chem
2 J Neurochem
2 J Neurosci
1 Nat Neurosci
2 Neurology
2 Neurosci Lett
2 PLoS One
1 Science

    Acta Neuropathol

  1. GRANHOLM AE, Englund E, Gilmore A, Head E, et al
    Neuropathological findings in Down syndrome, Alzheimer's disease and control patients with and without SARS-COV-2: preliminary findings.
    Acta Neuropathol. 2024;147:92.
    >> Share

    Alzheimer Dis Assoc Disord

  2. BANGERTER LR, Griffin JM, Kim K, Finnie DM, et al
    A Delphi Approach to Define Lucid Episodes in People Living With Dementia.
    Alzheimer Dis Assoc Disord. 2024;38:147-151.
    >> Share

  3. LIU H, Weakley AM, Zhang J, Liu X, et al
    A Transformer Approach for Cognitive Impairment Classification and Prediction.
    Alzheimer Dis Assoc Disord. 2024;38:189-194.
    >> Share

    Alzheimers Dement

  4. SOSA AL, Brucki SM, Crivelli L, Lopera FJ, et al
    Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City.
    Alzheimers Dement. 2024 May 27. doi: 10.1002/alz.13850.
    >> Share

  5. BISKADUROS A, Glodzik L, Saint Louis LA, Rusinek H, et al
    Longitudinal trajectories of Alzheimer's disease CSF biomarkers and blood pressure in cognitively healthy subjects.
    Alzheimers Dement. 2024 May 29. doi: 10.1002/alz.13800.
    >> Share

  6. PANYARD DJ, Reus LM, Ali M, Liu J, et al
    Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3.
    Alzheimers Dement. 2024 May 29. doi: 10.1002/alz.13848.
    >> Share


  7. ALTMANN A, Aksman LM, Oxtoby NP, Young A, et al
    Towards cascading genetic risk in Alzheimer's disease.
    Brain. 2024 May 31:awae176. doi: 10.1093.
    >> Share

    Brain Res

  8. FARHATULLAH, Chen X, Zeng D, Mehmood A, et al
    3-Way hybrid analysis using clinical and magnetic resonance imaging for early diagnosis of Alzheimer's disease.
    Brain Res. 2024 May 27:149021. doi: 10.1016/j.brainres.2024.149021.
    >> Share

    Curr Alzheimer Res

  9. SONG G, Wu H, Chen H, Zhang S, et al
    hdWGCNA and Cellular Communication Identify Active NK Cell Subtypes in Alzheimer's Disease and Screen for Diagnostic Markers through Machine Learning.
    Curr Alzheimer Res. 2024 May 28. doi: 10.2174/0115672050314171240527064514.
    >> Share

    Exp Gerontol

  10. SAFARBALOU A, Algarzae NK, Alsahly MB, Alsufayan TA, et al
    Oral administration of liposome-encapsulated thymol could alleviate the inflammatory parameters in serum and hippocampus in a rat model of Alzheimer's disease.
    Exp Gerontol. 2024 May 25:112473. doi: 10.1016/j.exger.2024.112473.
    >> Share

  11. XU Y, Xu M, Zhou C, Sun L, et al
    Ferroptosis and its implications in treating cognitive impairment caused by aging: A study on the mechanism of repetitive transcranial magnetic stimulation.
    Exp Gerontol. 2024;192:112443.
    >> Share

    Exp Neurol

  12. LI CL, Zhou GF, Xie XY, Wang L, et al
    STAU1 exhibits a dual function by promoting amyloidogenesis and tau phosphorylation in cultured cells.
    Exp Neurol. 2024;377:114805.
    >> Share

    Geriatrics (Basel)

  13. ZUIN M, De Vito A, Romagnoli T, Polastri M, et al
    Cerebral Blood Flow in Alzheimer's Disease: A Meta-Analysis on Transcranial Doppler Investigations.
    Geriatrics (Basel). 2024;9:58.
    >> Share

    J Alzheimers Dis

  14. ESPAY AJ, Herrup K, Imbimbo BP, Kepp KP, et al
    Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-beta42.
    J Alzheimers Dis. 2024;99:877-881.
    >> Share

  15. ILBOUDO Y, Yoshiji S, Lu T, Butler-Laporte G, et al
    Vitamin D, Cognition, and Alzheimer's Disease: Observational and Two-Sample Mendelian Randomization Studies.
    J Alzheimers Dis. 2024 May 27. doi: 10.3233/JAD-221223.
    >> Share

  16. ZHAO A, Balcer LJ, Himali JJ, O'Donnell A, et al
    Association of Loneliness with Functional Connectivity MRI, Amyloid-beta PET, and Tau PET Neuroimaging Markers of Vulnerability for Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 28. doi: 10.3233/JAD-231425.
    >> Share

  17. GENG Z, Wu Y, Liu J, Zhan Y, et al
    A Study on the Effect of Executive Control Network Functional Connection on the Therapeutic Efficacy of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 24. doi: 10.3233/JAD-231449.
    >> Share

    J Biol Chem

  18. YAKOUT DW, Shroff A, Wei W, Thaker V, et al
    Tau regulates Arc stability in neuronal dendrites via a proteasome-sensitive but ubiquitin-independent pathway.
    J Biol Chem. 2024;300:107237.
    >> Share

    J Neurochem

  19. ISEI MO, Girardi PA, Rodwell-Bullock J, Nehrke K, et al
    Site-specific phosphorylation of tau impacts mitochondrial function and response to stressors.
    J Neurochem. 2024;168:1019-1029.
    >> Share

  20. CHEN Y, Zeng X, Diaz JL, Sehrawat A, et al
    Effect of blood collection tube containing protease inhibitors on the pre-analytical stability of Alzheimer's disease plasma biomarkers.
    J Neurochem. 2024 May 30. doi: 10.1111/jnc.16130.
    >> Share

    J Neurosci

  21. JACOBSON KR, Song H
    Changes in the Extracellular Matrix with Aging: A Larger Role in Alzheimer's Disease.
    J Neurosci. 2024;44:e0081242024.
    >> Share

  22. Erratum: Iba et al., "Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy".
    J Neurosci. 2024 May 28:e0865242024. doi: 10.1523/JNEUROSCI.0865-24.2024.
    >> Share


  23. HARRIS E
    Study: 2 APOE4 Copies May Indicate Genetic Form of Alzheimer Disease.
    JAMA. 2024 May 31. doi: 10.1001/jama.2024.9649.
    >> Share

    Nat Neurosci

  24. HUANG Y, Wang M, Ni H, Zhang J, et al
    Regulation of cell distancing in peri-plaque glial nets by Plexin-B1 affects glial activation and amyloid compaction in Alzheimer's disease.
    Nat Neurosci. 2024 May 27. doi: 10.1038/s41593-024-01664.
    >> Share


  25. JADICK MF, Robinson T, Farrell ME, Klinger H, et al
    Associations Between Self and Study Partner Report of Cognitive Decline With Regional Tau in a Multicohort Study.
    Neurology. 2024;102:e209447.
    >> Share

  26. YE R, Goodheart AE, Locascio JJ, Peterec E, et al
    Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases.
    Neurology. 2024;102:e209460.
    >> Share

    Neurosci Lett

  27. YANG C, Wu X, Feng J, Wu C, et al
    Clinical values of serum C5a in Alzheimer's disease patients with different dementia stages.
    Neurosci Lett. 2024 May 23:137833. doi: 10.1016/j.neulet.2024.137833.
    >> Share

  28. TU Y, Xu B
    Esketamine induces tripartite motif-containing protein 24 to improve cognitive dysfunction in Alzheimer's disease.
    Neurosci Lett. 2024 May 25:137836. doi: 10.1016/j.neulet.2024.137836.
    >> Share

    PLoS One

  29. AZIZAN Z, Zali H, Mirmotalebisohi SA, Bazrgar M, et al
    Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer's disease through a systems biology approach and drug repurposing.
    PLoS One. 2024;19:e0304410.
    >> Share

  30. FELDMAN HH, Luchsinger JA, Leger GC, Taylor C, et al
    Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam).
    PLoS One. 2024;19:e0302998.
    >> Share


  31. PRINCEN K, Van Dooren T, van Gorsel M, Louros N, et al
    Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer's disease.
    Science. 2024;384:eadd6260.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016